Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
303.66
+5.77 (1.94%)
At close: Aug 29, 2025, 4:00 PM
304.38
+0.72 (0.24%)
After-hours: Aug 29, 2025, 7:59 PM EDT
Humana Stock Forecast
Stock Price Forecast
The 21 analysts that cover Humana stock have a consensus rating of "Hold" and an average price target of $281.71, which forecasts a -7.23% decrease in the stock price over the next year. The lowest target is $250 and the highest is $344.
Price Target: $281.71 (-7.23%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Humana stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 6 | 5 | 5 | 5 | 5 |
| Hold | 17 | 15 | 15 | 15 | 15 | 16 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 21 | 21 | 21 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $283 → $322 | Buy | Maintains | $283 → $322 | +6.04% | Aug 21, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $348 → $344 | Buy | Maintains | $348 → $344 | +13.28% | Aug 14, 2025 |
| Argus Research | Argus Research | Hold Reiterates $282 | Hold | Reiterates | $282 | -7.14% | Aug 14, 2025 |
| Barclays | Barclays | Hold Maintains $268 → $275 | Hold | Maintains | $268 → $275 | -9.44% | Jul 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $290 → $277 | Hold | Maintains | $290 → $277 | -8.78% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
129.60B
from 117.76B
Increased by 10.05%
Revenue Next Year
135.60B
from 129.60B
Increased by 4.64%
EPS This Year
17.21
from 9.98
Increased by 72.40%
EPS Next Year
13.75
from 17.21
Decreased by -20.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 135.5B | 153.3B | |||
| Avg | 129.6B | 135.6B | |||
| Low | 124.4B | 119.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 18.3% | |||
| Avg | 10.1% | 4.6% | |||
| Low | 5.7% | -8.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.17 | 16.64 | |||
| Avg | 17.21 | 13.75 | |||
| Low | 15.86 | 10.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 82.0% | -3.3% | |||
| Avg | 72.4% | -20.1% | |||
| Low | 58.9% | -40.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.